Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime E C Hallak

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Archives of General Psychiatry|February 6, 2008
Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging studyJ F William Deakin, Jane Lees, Shane McKie, et al.
Frontiers in Pharmacology|October 18, 2016
Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified CannabidiolJosé A S Crippa, Ana C S Crippa, Jaime E C Hallak, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|March 27, 2010
National Science and Technology Institute for Translational Medicine (INCT-TM): advancing the field of translational medicine and mental healthJaime E C Hallak, José Alexandre S Crippa, João Quevedo, et al.
Frontiers in Pharmacology|June 6, 2018
Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?Fernanda F Peres, Alvaro C Lima, Jaime E C Hallak, et al.
CNS & Neurological Disorders Drug Targets|June 14, 2014
Neuroimaging correlates of pharmacological and psychological treatments for specific phobiaIla M Linares, Marcos H N Chags, João P Machado-de-Sousa, et al.
Therapeutic Advances in Psychopharmacology|June 30, 2016
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 yearsRafael G Dos Santos, Flávia L Osório, José Alexandre S Crippa, et al.
Molecules (Basel, Switzerland)|May 6, 2020
Stability Evaluation of DMT and Harmala Alkaloids in Ayahuasca Tea SamplesGabriela de Oliveira Silveira, Rafael Guimarães Dos Santos, Felipe Rebello Lourenço, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 2, 2019
Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms?José Alexandre S Crippa, Jaime E C Hallak, Antônio W Zuardi, et al.
Acta Neuropsychiatrica|March 26, 2024
Cannabidiol modulates hippocampal genes involved in mitochondrial function, ribosome biogenesis, synapse organization, and chromatin modificationsJoão P D Machado, Valéria de Almeida, Antonio W Zuardi, et al.
Journal of Psychoactive Drugs|May 28, 2016
Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and HumansAmanda A Nunes, Rafael G Dos Santos, Flávia L Osório, et al.
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Archives of General Psychiatry|February 6, 2008
Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging studyJ F William Deakin, Jane Lees, Shane McKie, et al.
Frontiers in Pharmacology|October 18, 2016
Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified CannabidiolJosé A S Crippa, Ana C S Crippa, Jaime E C Hallak, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|March 27, 2010
National Science and Technology Institute for Translational Medicine (INCT-TM): advancing the field of translational medicine and mental healthJaime E C Hallak, José Alexandre S Crippa, João Quevedo, et al.
Frontiers in Pharmacology|June 6, 2018
Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?Fernanda F Peres, Alvaro C Lima, Jaime E C Hallak, et al.
CNS & Neurological Disorders Drug Targets|June 14, 2014
Neuroimaging correlates of pharmacological and psychological treatments for specific phobiaIla M Linares, Marcos H N Chags, João P Machado-de-Sousa, et al.
Therapeutic Advances in Psychopharmacology|June 30, 2016
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 yearsRafael G Dos Santos, Flávia L Osório, José Alexandre S Crippa, et al.
Molecules (Basel, Switzerland)|May 6, 2020
Stability Evaluation of DMT and Harmala Alkaloids in Ayahuasca Tea SamplesGabriela de Oliveira Silveira, Rafael Guimarães Dos Santos, Felipe Rebello Lourenço, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 2, 2019
Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms?José Alexandre S Crippa, Jaime E C Hallak, Antônio W Zuardi, et al.
Acta Neuropsychiatrica|March 26, 2024
Cannabidiol modulates hippocampal genes involved in mitochondrial function, ribosome biogenesis, synapse organization, and chromatin modificationsJoão P D Machado, Valéria de Almeida, Antonio W Zuardi, et al.
Journal of Psychoactive Drugs|May 28, 2016
Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and HumansAmanda A Nunes, Rafael G Dos Santos, Flávia L Osório, et al.
Pageof 13